Shares of Torrent Pharmaceuticals recovered from early losses to settle over 1 per cent higher despite the company receiving a warning letter from the US health regulator for its Indrad facility in Gujarat.
During the day, stock of the drug firm slumped 6.69 per cent to Rs 1,554.65. However, it managed to pare early losses to settle 1.44 per cent higher at Rs 1,690.10 on the BSE.
On the NSE, the scrip touched intra-day low of Rs 1,555, down 6.67 per cent, before recovering to close 1.43 per cent higher at Rs 1,690.
The company on Wednesday said it has received a warning letter from the US health regulator for its Indrad facility in Gujarat.
This action by the United States Food and Drug Administration (USFDA) follows earlier intimation received from the regulator in August, wherein the agency had classified its inspection as "Official Action Indicated" (OAI), Torrent Pharma said in a regulatory filing on Wednesday.
The company does not believe that the warning letter will have an impact of disruption of supplies or the existing revenues from operations of this facility, it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
